探索缺血核心生长率和内血管治疗对大核心患者的益处
Longting Lin1,2, Yueming Wang3,4, Chushuang Chen2
1South West Sydney Clinical Campuses, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
概括
快速增长的缺血性中风核心可能从内血管血栓切除中获益最多. 这种治疗显著减少了核心增长超快的患者的不良结果,这表明干预的关键窗口.
科学领域:
- 神经学 神经学
- 脑卒中医学 脑卒中医学
- 干预性神经放射学 干预性神经放射学
背景情况:
- 缺血性中风的进展到心脏病发作取决于恢复血液流动.
- 核心生长率量化了中风后发作的心脏病发作速度.
- 血管内血栓切除术是一种针对大缺血核心中风的再注射治疗方法.
研究的目的:
- 为了研究核心生长速度是否影响内血管血栓切除,在大型缺血性核心中风患者中受益.
- 根据核心增长率和治疗分配来分层结果.
主要方法:
- 在134名大缺血核心中风患者 (>70毫升核心体积在9小时内) 的多中心队列研究中.
- 通过脑输液成像评估的患者.
- 血管内血栓切除术 (n=71) 和不接受治疗 (n=63) 组之间的结果比较,按核心生长速度分层 (>70毫升/小时 vs. <70毫升/小时).
主要成果:
- 总体而言,治疗后的不良结果 (3个月的残疾/死亡) 为56%,而没有治疗时为68% (p=0.156).
- "核心增长超快" (>70毫升/小时) 的患者在进行血栓切除后的不良结果显著降低 (60%) 与没有治疗的患者相比 (93%,p=0.033).
- 核心生长速度较慢的患者 (<70毫升/小时) 在治疗组之间的不良结果中没有显著差异 (55%对61%,p=0.522).
结论:
- 核心生长速度是确定内血管血栓切除术疗效的关键因素.
- 经历"超快的核心生长"的患者可能会从及时的内血管血栓切除中获得最显著的益处.
- 基于中风进展动态的时间敏感干预措施的进一步研究是有必要的.
相关概念视频
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Vascular Spasm
1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
150
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
150
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
165
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
165
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Vascular Resistance
3.7K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.7K


